Treatment of cluster headache in pregnancy and lactation

Cephalalgia

Volumn 29, Issue 4, 2009, Pages 391-400

  Jürgens, Tp ^a,b,d   Schaefer, C ^c   May, A ^d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Pharmakovigilanz und Beratungszentrum Embryonaltoxikologie   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Cluster headache; Lactation; Pregnancy; Treatment; Triptan

Indexed keywords

ALMOTRIPTAN; CAPSAICIN; CORTICOSTEROID; DIHYDROERGOTAMINE; ELETRIPTAN; ERGOTAMINE; ERGOTAMINE DERIVATIVE; FROVATRIPTAN; GABAPENTIN; LIDOCAINE; LITHIUM; LITHIUM CARBONATE; MELATONIN; METHYSERGIDE; NARATRIPTAN; OXYGEN; PIZOTIFEN; PREDNISOLONE; RIZATRIPTAN; SUMATRIPTAN; TOPIRAMATE; VALPROIC ACID; VERAPAMIL; ZOLMITRIPTAN;

ABSENCE OF SIDE EFFECTS; ANALGESIA; BIRTH DEFECT; BRAIN DEPTH STIMULATION; BREAST FEEDING; CATARACT; CLEFT LIP; CLEFT PALATE; CLUSTER HEADACHE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DRUG BLOOD LEVEL; EMBRYOTOXICITY; FACE DYSMORPHIA; FAMILY PLANNING; FETOTOXICITY; FETUS DISEASE; FINGER MALFORMATION; GOITER; GROWTH RETARDATION; GYNECOLOGY; HEART ARRHYTHMIA; HEART VENTRICLE SEPTUM DEFECT; HIRSUTISM; HUMAN; HYDRAMNIOS; HYPOSPADIAS; LACTATION; LIMB REDUCTION DEFECT; MICROPHTHALMIA; NEUROLOGIC DISEASE; NEWBORN; NEWBORN DISEASE; NEWBORN JAUNDICE; PAIN; POLYURIA; PRACTICE GUIDELINE; PREGNANCY; PREMATURE LABOR; REVIEW; RISK; SIDE EFFECT; SPINA BIFIDA; STILLBIRTH; SUPRAVENTRICULAR TACHYCARDIA; TERATOGENICITY; UNSPECIFIED SIDE EFFECT;

ANALGESICS; CLUSTER HEADACHE; FEMALE; HUMANS; INFANT, NEWBORN; LACTATION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 61849167069     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01764.x     Document Type: Review

References (79)

1. Ekbom K, Waldenlind E. Cluster headache in women: evidence of hypofertility(?) Headaches in relation to menstruation and pregnancy. Cephalalgia 1981 1 : 167 74.
2. Manzoni GC, Micieli G, Granella F, Martignoni E, Farina S, Nappi G. Cluster headache in women: clinical findings and relationship with reproductive life. Cephalalgia 1988 8 : 37 44.
3. van Vliet JA, Favier I, Helmerhorst FM, Haan J, Ferrari MD. Cluster headache in women: relation with menstruation, use of oral contraceptives, pregnancy, and menopause. J Neurol Neurosurg Psychiatry 2006 77 : 690 2.
4. Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002 58 : 354 61.
5. Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003 23 : 197 205.
6. May A, Leone M, Afra J, Linde M, Sandor PS, Evers S et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 2006 13 : 1066 77.
7. Dodick DW, Rozen TD, Goadsby PJ, Silberstein SD. Cluster headache. Cephalalgia 2000 20 : 787 803.
8. May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet 2005 366 : 843 55.
9. Leone M, Franzini A, Broggi G, Bussone G. Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology 2006 67 : 150 2.
10. Leone M, Franzini A, Bussone G. Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med 2001 345 : 1428 9.
11. Starr PA, Barbaro NM, Raskin NH, Ostrem JL. Chronic stimulation of the posterior hypothalamic region for cluster headache: technique and 1-year results in four patients. J Neurosurg 2007 106 : 999 1005.
12. Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet 2007 369 : 1099 106.
13. Magis D, Allena M, Bolla M, De Pasqua V, Remacle JM, Schoenen J. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol 2007 6 : 314 21.
14. Loder EW, Massiou H. Headache during pregnancy and lactation. In : Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The headaches, 3rd edn. Philadelphia, PA : Lippincott, Williams & Wilkins 2006 : 1091 8.
15. Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D'Amico D. Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci 2004 25 (Suppl. 3 S105 7.
16. Scialli AR, Buelke-Sam JL, Chambers CD, Friedman JM, Kimmel CA, Polifka JE et al. Communicating risks during pregnancy: a workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs. Birth Defects Res A Clin Mol Teratol 2004 70 : 7 12.
17. Webster WS, Freeman JA. Is this drug safe in pregnancy? Reprod Toxicol 2001 15 : 619 29.
18. Briggs GG, Freeman RK, Yaffe SJ. Classification of drugs for teratogenic risk: an anachronistic way of counseling: a reply to Merlob and Stahl. Birth Defects Res A Clin Mol Teratol 2003 67 : 207 8.
19. Silberstein SD, Saper JR, Freitag FG. Migraine: diagnosis and treatment. In : Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff's headache and other head pain, 7th edn. New York : Oxford University Press 2001 : 121 237.
20. Eldridge RE, Ephross SA, Committee SRA. Monitoring birth outcomes in the sumatriptan pregnancy registry. Teratology 1997 55 : 48.
21. GlaxoSmithKline. Sumatriptan and Naratriptan Pregnancy Registry. International Interim Report: 1 January 1996 through 30 April 2005. Wilmington, DC : GlaxoSmithKline 2005.
22. O'Quinn S, Ephross SA, Williams V, Davis RL, Gutterman DL, Fox AW. Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch Gynecol Obstet 1999 263 : 7 12.
23. Reiff-Eldridge R, Heffner CR, Ephross SA, Tennis PS, White AD, Andrews EB. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. Am J Obstet Gynecol 2000 182 (1 Pt 1 159 63.
24. Shuhaiber S, Pastuszak A, Schick B, Matsui D, Spivey G, Brochu J et al. Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 1998 51 : 581 3.
25. Kallen B, Lygner PE. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 2001 41 : 351 6.
26. Olesen C, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. Pregnancy outcome following prescription for sumatriptan. Headache 2000 40 : 20 4.
27. Wojnar-Horton RE, Hackett LP, Yapp P, Dusci LJ, Paech M, Ilett KF. Distribution and excretion of sumatriptan in human milk. Br J Clin Pharmacol 1996 41 : 217 21.
28. Schaefer C, Spielmann H, Vetter K. Arzneiverordnung in Schwangerschaft und Stillzeit, 7th edn. München : Elsevier/Urban & Fischer 2006.
29. Soldin OP, Dahlin J, O'Mara DM. Triptans in pregnancy. Ther Drug Monit 2008 30 : 5 9.
30. Fiore M, Shields KE, Santanello N, Goldberg MR. Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004. Cephalalgia 2005 25 : 685 8.
31. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA : John Wright-PSG 1977.
32. Guay J, Gaudreault P, Boulanger A, Tang A, Lortie L, Dupuis C. Lidocaine hydrocarbonate and lidocaine hydrochloride for cesarean section: transplacental passage and neonatal effects. Acta Anaesthesiol Scand 1992 36 : 722 7.
33. Ortega D, Viviand X, Lorec AM, Gamerre M, Martin C, Bruguerolle B. Excretion of lidocaine and bupivacaine in breast milk following epidural anesthesia for cesarean delivery. Acta Anaesthesiol Scand 1999 43 : 394 7.
34. Giuliani M, Grossi GB, Pileri M, Lajolo C, Casparrini G. Could local anesthesia while breast-feeding be harmful to infants? J Pediatr Gastroenterol Nutr 2001 32 : 142 4.
35. Fox AW, Diamond ML, Spierings EL. Migraine during pregnancy: options for therapy. CNS Drugs 2005 19 : 465 81.
36. Silberstein SD. Headaches in pregnancy. Neurol Clin 2004 22 : 727 56.
37. Hughes HE, Goldstein DA. Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine. J Med Genet 1988 25 : 396 9.
38. Schaefer C, Peters PWJ, Miller R. Drugs during pregnancy and lactation. Treatment options and risk. assessment, 2nd edn. Amsterdam, New York : Elsevier/Academic Press 2007.
39. Raymond GV. Teratogen update: ergot and ergotamine. Teratology 1995 51 : 344 7.
40. Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996 174 : 823 8.
41. Marlettini M, Crippa S, Morselli-Labate A, Contarini A, Orlandi C. Randomized comparison of calcium antatgonists and beta-blockers in the treatment of pregnancy-induced hypertension. Curr Ther Res 1990 48 : 684 94.
42. Orlandi C, Marlettini M, Cassania A, Trabatti M, Agostini D, Salomone T et al. Treatment of hypertension during pregnancy with the calcium antagonist verapamil. Curr Ther Res 1986 39 : 884 93.
43. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 7th edn. Baltimore, MD : Williams & Wilkins 2005.
44. Shen O, Entebi E, Yagel S. Congenital hypertrophic cardiomyopathy associated with in utero verapamil exposure. Prenat Diagn 1995 15 : 1088 9.
45. Bennett PN. Drugs and human lactation, 2nd edn. Amsterdam : Elsevier 1996.
46. Kozma C. Neonatal toxicity and transient neurodevelopmental deficits following prenatal exposure to lithium: Another clinical report and a review of the literature. Am J Med Genet A 2005 132 : 441 4.
47. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A reevaluation of risk of in utero exposure to lithium. JAMA 1994 271 : 146 50.
48. Jacobson SJ, Jones K, Johnson K, Ceolin L, Kaur P, Sahn D et al. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992 339 : 530 3.
49. Zalzstein E, Koren G, Einarson T, Freedom RM. A case-control study on the association between first trimester exposure to lithium and Ebstein's anomaly. Am J Cardiol 1990 65 : 817 18.
50. Shepard TH, Brent RL, Friedman JM, Jones KL, Miller RK, Moore CA et al. Update on new developments in the study of human teratogens. Teratology 2002 65 : 153 61.
51. Pinelli JM, Symington AJ, Cunningham KA, Paes BA. Case report and review of the perinatal implications of maternal lithium use. Am J Obstet Gynecol 2002 187 : 245 9.
52. Moretti ME, Koren G, Verjee Z, Ito S. Monitoring lithium in breast milk: an individualized approach for breast-feeding mothers. Ther Drug Monit 2003 25 : 364 6.
53. Spigset O, Hagg S. Excretion of psychotropic drugs into breast milk: pharmacokinetic overview and therapeutic implications. CNS Drugs 1998 9 : 111 34.
54. Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004 18 : 93 101.
55. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000 62 : 385 92.
56. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 1999 86 : 242 4.
57. Kallen B. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate Craniofac J 2003 40 : 624 8.
58. Pradat P, Robert-Gnansia E, Di Tanna GL, Rosano A, Lisi A, Mastroiacovo P. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol 2003 67 : 968 70.
59. Rodriguez-Pinilla E, Martinez-Frias ML. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 1998 58 : 2 5.
60. Greenberger PA, Odeh YK, Frederiksen MC, Atkinson AJ Jr. Pharmacokinetics of prednisolone transfer to breast milk. Clin Pharmacol Ther 1993 53 : 324 8.
61. Hoyme HE, Hauck L, Quinn D. Minor anomalies accompanying prenatal exposure to topiramate. J Invest Med 1998 46 : 119.
62. Yerby MS. Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia 2003 44 (Suppl. 3 33 40.
63. Ohman I, Vitols S, Luef G, Soderfeldt B, Tomson T. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 2002 43 : 1157 60.
64. Vajda FJ, O'Brien TJ, Hitchcock A, Graham J, Lander C. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months. J Clin Neurosci 2003 10 : 543 9.
65. Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006 77 : 193 8.
66. Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 2003 4 : 310 17.
67. Wilton LV, Shakir S. A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England. Epilepsia 2002 43 : 983 92.
68. Chambers CD, Kao KK, Felix RJ, Alvarado S, Chavez C, Dick LM et al. Pregnancy outcome in infants prenatally exposed to newer anticonvulsants. Birth Defects Res A Clin Mol Teratol 2005 73 : 316.
69. Hagg S, Spigset O. Anticonvulsant use during lactation. Drug Saf 2000 22 : 425 40.
70. Ohman I, Vitols S, Tomson T. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia 2005 46 : 1621 4.
71. Vajda FJ, Eadie MJ. Maternal valproate dosage and foetal malformations. Acta Neurol Scand 2005 112 : 137 43.
72. Piontek CM, Baab S, Peindl KS, Wisner KL. Serum valproate levels in 6 breastfeeding mother-infant pairs. J Clin Psychiatry 2000 61 : 170 2.
73. Ujhazy E, Nosal R, Zeljenkova D, Balonova T, Chalupa I, Siracky J et al. Teratological and cytogenetical evaluation of two antihistamines (pipethiadene and pizotifen maleate) in mice. Agents Actions 1988 23 : 376 8.
74. Chanda S, Sharper V, Hoberman A, Bley K. Developmental toxicity study of pure trans-capsaicin in rats and rabbits. Int J Toxicol 2006 25 : 205 17.
75. Davis FC. Melatonin: role in development. J Biol Rhythms 1997 12 : 498 508.
76. Illnerova H, Buresova M, Presl J. Melatonin rhythm in human milk. J Clin Endocrinol Metab 1993 77 : 838 41.
77. Leone M, May A, Franzini A, Broggi G, Dodick D, Rapoport A et al. Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection. Cephalalgia 2004 24 : 934 7.
78. Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003 61 (6 Suppl. 2 S35 42.
79. Tomson T, Battino D. Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet 2007 46 : 209 19.